Robert W. Duggan, Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 189,698,406 shares at $0.97 ($184.0M) on 2022-08-16, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.97 | 94,849,203 | $92.0M | 50.0% |
| 2 | $0.97 | 94,849,203 | $92.0M | 50.0% |
| Total | $0.97 avg | 189,698,406 | $184.0M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |